• 137
  • 11
  • 收藏

Valneva SE surged over 30% in premarket trading

Tiger Newspress2021-10-18

(Oct 18) Valneva shares jumped 30% in Paris trading after saying its coronavirus vaccine candidate outperformed AstraZeneca's in a Phase 3 study, which met both its co-primary endpoints. Valneva said its vaccine had a neutralizing antibody seroconversion rate above 95% and that it had a better tolerability profile.

免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。

举报

评论11

  • PowerTrade
    ·2021-10-19
    Like all
    回复
    举报
    收起
    • Yao84
      Yup
      2021-10-19
      回复
      举报
  • FrederickL
    ·2021-10-19
    Like pls.  
    回复
    举报
  • AxelOng
    ·2021-10-18
    Cool
    回复
    举报
    收起
    • 2b8a22ff
      Okay
      2021-10-18
      回复
      举报
  • Delfort
    ·2021-10-18
    Thanks great
    回复
    举报
  • JoelLee
    ·2021-10-18
    Buy buy!
    回复
    举报
    收起
    • Investcub
      It does appear to be a good buy….
      2021-10-18
      回复
      举报
  • pralala
    ·2021-10-18
    Yi
    回复
    举报
    收起
    • pralala
      F
      2021-11-01
      回复
      举报
  • Dex2021
    ·2021-10-18
    Continue to surge or pullback? Like pls
    回复
    举报
    收起
    • Ghtan
      Yes pls
      2021-10-18
      回复
      举报
  • HR88
    ·2021-10-18
    Like and comment pls
    回复
    举报
    收起
    • DL97
      Likezz
      2021-10-19
      回复
      举报
  • Never ever f
    ·2021-10-18
    Woooo
    回复
    举报
  • GiselleC
    ·2021-10-18
    I c
    回复
    举报
  • CIG
    ·2021-10-18
    If some negative news appear later, how?
    回复
    举报
    收起
    • MichaelPoh
      short sell
      2021-10-18
      回复
      举报
 
 
 
 

热议股票

 
 
 
 
 

7x24